| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | synapse organization | FRMPD4 ANK3 NRCAM PPFIBP1 PCLO PCDHB10 PCDHB9 NFASC SEZ6L2 DCTN1 TAOK2 NLGN3 PTPRD SLC18A3 AFG3L2 DOCK7 ROBO2 PPP1R9B CDH2 CDH9 SEMA3E | 8.11e-07 | 685 | 183 | 21 | GO:0050808 |
| GeneOntologyBiologicalProcess | cell junction organization | FRMPD4 ANK3 NRCAM PPFIBP1 PCLO PCDHB10 PCDHB9 NFASC SEZ6L2 DCTN1 TAOK2 NLGN3 PTPRD SLC18A3 AFG3L2 DOCK7 ROBO2 PPP1R9B KDR CDH2 CDH9 CDH12 CXADR TBCD SEMA3E | 1.78e-06 | 974 | 183 | 25 | GO:0034330 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | NRCAM CDHR2 PCDHGA3 PCDHB10 PCDHB9 TAOK2 PTPRD ROBO2 CDH2 CDH9 CDH12 CXADR | 2.44e-05 | 313 | 183 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | clustering of voltage-gated sodium channels | 3.72e-05 | 8 | 183 | 3 | GO:0045162 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.58e-05 | 187 | 183 | 9 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell junction assembly | NRCAM PCLO PCDHB10 PCDHB9 NFASC TAOK2 NLGN3 PTPRD DOCK7 ROBO2 PPP1R9B KDR CDH2 CDH9 CDH12 TBCD | 5.02e-05 | 569 | 183 | 16 | GO:0034329 |
| GeneOntologyBiologicalProcess | synapse assembly | NRCAM PCLO PCDHB10 PCDHB9 NLGN3 PTPRD DOCK7 ROBO2 PPP1R9B CDH2 CDH9 | 1.01e-04 | 308 | 183 | 11 | GO:0007416 |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.06e-04 | 53 | 183 | 5 | GO:0016339 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | DCAF1 A1CF ERCC6 ARID4B NUP210L MRPL44 BARD1 SIN3A EZH1 SF1 BAP1 KMT2C DDX46 SF3B1 SCNM1 NUP155 INTS2 TINF2 NFE2L2 ACTR6 PABPC3 NFYA DOCK7 SUGP1 BOD1L1 PRKDC CDC5L LSM7 HDAC1 | 7.57e-06 | 1377 | 181 | 29 | GO:0140513 |
| GeneOntologyCellularComponent | ciliary pocket membrane | 2.22e-04 | 3 | 181 | 2 | GO:0020018 | |
| GeneOntologyCellularComponent | ciliary pocket | 2.22e-04 | 3 | 181 | 2 | GO:0020016 | |
| Domain | fn3 | 2.57e-05 | 162 | 178 | 9 | PF00041 | |
| Domain | FN3 | 7.24e-05 | 185 | 178 | 9 | SM00060 | |
| Domain | Cadherin_CS | 8.35e-05 | 109 | 178 | 7 | IPR020894 | |
| Domain | SOCS | 9.03e-05 | 2 | 178 | 2 | PF12610 | |
| Domain | SOCS4/SOCS5_dom | 9.03e-05 | 2 | 178 | 2 | IPR022252 | |
| Domain | EHD1/EHD3 | 9.03e-05 | 2 | 178 | 2 | IPR029951 | |
| Domain | CADHERIN_1 | 1.05e-04 | 113 | 178 | 7 | PS00232 | |
| Domain | Cadherin | 1.05e-04 | 113 | 178 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 1.11e-04 | 114 | 178 | 7 | PS50268 | |
| Domain | - | 1.11e-04 | 114 | 178 | 7 | 2.60.40.60 | |
| Domain | CA | 1.17e-04 | 115 | 178 | 7 | SM00112 | |
| Domain | AT_hook | 1.18e-04 | 27 | 178 | 4 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 1.18e-04 | 27 | 178 | 4 | IPR017956 | |
| Domain | Cadherin-like | 1.24e-04 | 116 | 178 | 7 | IPR015919 | |
| Domain | FN3 | 1.26e-04 | 199 | 178 | 9 | PS50853 | |
| Domain | Cadherin | 1.38e-04 | 118 | 178 | 7 | IPR002126 | |
| Domain | FN3_dom | 1.83e-04 | 209 | 178 | 9 | IPR003961 | |
| Domain | Opioid_neupept | 2.69e-04 | 3 | 178 | 2 | IPR006024 | |
| Domain | Opiods_neuropep | 2.69e-04 | 3 | 178 | 2 | PF01160 | |
| Domain | OPIOIDS_PRECURSOR | 2.69e-04 | 3 | 178 | 2 | PS01252 | |
| Domain | Ig_I-set | 4.84e-04 | 190 | 178 | 8 | IPR013098 | |
| Domain | I-set | 4.84e-04 | 190 | 178 | 8 | PF07679 | |
| Domain | Neurofascin/L1/NrCAM_C | 5.35e-04 | 4 | 178 | 2 | IPR026966 | |
| Domain | Toprim | 5.35e-04 | 4 | 178 | 2 | PF01751 | |
| Domain | Bravo_FIGEY | 5.35e-04 | 4 | 178 | 2 | PF13882 | |
| Domain | Toprim_domain | 5.35e-04 | 4 | 178 | 2 | IPR006171 | |
| Domain | TOPRIM | 5.35e-04 | 4 | 178 | 2 | PS50880 | |
| Domain | VWA_N | 8.86e-04 | 5 | 178 | 2 | IPR013608 | |
| Domain | VWA_N | 8.86e-04 | 5 | 178 | 2 | PF08399 | |
| Domain | EHD_N | 8.86e-04 | 5 | 178 | 2 | IPR031692 | |
| Domain | HnRNP_R/Q_splicing_fac | 8.86e-04 | 5 | 178 | 2 | IPR006535 | |
| Domain | EHD_N | 8.86e-04 | 5 | 178 | 2 | PF16880 | |
| Domain | HEAT | 1.12e-03 | 48 | 178 | 4 | PF02985 | |
| Domain | Peptidase_M12A | 1.32e-03 | 6 | 178 | 2 | IPR001506 | |
| Domain | Astacin | 1.32e-03 | 6 | 178 | 2 | PF01400 | |
| Pubmed | STAM2 TES ANK3 PSMC2 SIN3A ARHGAP35 DCTN1 GTF3C3 KMT2C NCAPG DDX46 DOCK7 BOD1L1 PRKDC CDC5L DOT1L TOP2A ZMYM4 HDAC1 | 1.31e-10 | 549 | 184 | 19 | 38280479 | |
| Pubmed | LRRC8E STAM2 SALL4 BRD3 SIN3A EZH1 GTF3C3 KMT2C NCAPG INTS2 AFG3L2 TNRC6A BOD1L1 CDC5L PHIP TOP2A ZMYM4 | 6.40e-10 | 469 | 184 | 17 | 27634302 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | ERCC6 ARID4B KDM5A BARD1 BRD3 SIN3A MCM10 GTF3C3 BAP1 SPIN1 BOD1L1 HERC2 DOT1L USP48 DDX24 PHIP TOP2A ZMYM4 HDAC1 | 7.16e-10 | 608 | 184 | 19 | 36089195 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | LRRC8E DCAF1 FLOT2 GOLM2 CYP51A1 NFASC SIN3A URB2 CALML5 SF1 GTF3C3 P4HTM SF3B1 NUP155 INTS2 SCD CLPTM1 AFG3L2 TMEM132A DOCK7 PRKDC CDH2 TOP2A ZMYM4 CXADR TBCD | 1.27e-09 | 1203 | 184 | 26 | 29180619 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ARID4B KDM5A BARD1 BRD3 SIN3A SF1 BAP1 KMT2C KANSL2 DDX46 SF3B1 INTS2 TINF2 NFE2L2 ACTR6 SCD AFG3L2 PRKDC CDC5L DDX24 LSM7 TOP2A ZMYM4 TOP3A HDAC1 | 2.48e-08 | 1294 | 184 | 25 | 30804502 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | ERCC6 ARID4B MRPL44 BARD1 DARS1 TACC2 SIN3A URB2 MCM10 GTF3C3 DDX46 NUP155 NEMF PRKDC HERC2 CDC5L DDX24 TOP2A HDAC1 | 2.58e-08 | 759 | 184 | 19 | 35915203 |
| Pubmed | VPS37C FLOT2 DMXL2 ABAT FRMPD4 ANK3 NRCAM PCLO PSMC2 DARS1 TACC2 ZDBF2 ARHGAP35 TAOK2 OSBP SF3B1 SCD AFG3L2 TNRC6A DOCK7 PPP1R9B CRYBG3 CXADR | 4.29e-08 | 1139 | 184 | 23 | 36417873 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | DCAF1 VPS37C FLOT2 TES NAA10 TACC2 CPS1 DCTN1 GTF3C3 BAP1 PTTG3P KANSL2 DDX46 SF3B1 NUP155 CCDC15 PRKDC HERC2 CDC5L TOP2A ZMYM4 TOP3A TBCD | 5.51e-08 | 1155 | 184 | 23 | 20360068 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | VPS37C NRDE2 FLOT2 DMXL2 KDM5A MRPL44 CYP51A1 BRD3 ARHGAP35 SF1 GTF3C3 DDX46 SF3B1 SPIN1 NEMF DOCK7 SUGP1 PRKDC CDC5L DDX24 LSM7 TNXB | 7.67e-08 | 1082 | 184 | 22 | 38697112 |
| Pubmed | DMXL2 ANK3 NRCAM KDM5A USP11 PPFIBP1 DARS1 CACHD1 VPS26A DCTN1 SF1 KANSL2 P4HTM SF3B1 PTPRD NFE2L2 NEMF ASPA CCDC15 TAOK1 PRKDC HERC2 CTSB ZMYM4 | 9.08e-08 | 1285 | 184 | 24 | 35914814 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDC42BPG ABAT ANK3 GOLM2 ETV1 TMEM63C BARD1 NFASC ACVR2B ARHGAP35 EHD3 KMT2C NLGN3 INTS2 SPIN1 NEMF ANKIB1 CDK5RAP1 PPP1R9B BOD1L1 PNPLA7 POLK LSM7 ZMYM4 NSMAF TBCD | 9.42e-08 | 1489 | 184 | 26 | 28611215 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | STAM2 FLOT2 TES PSMC2 DARS1 TACC2 SIN3A ARHGAP35 CALML5 DCTN1 SF1 DDX46 SF3B1 AFG3L2 SUGP1 PPP1R9B BOD1L1 PRKDC CDC5L TOP2A | 1.38e-07 | 934 | 184 | 20 | 33916271 |
| Pubmed | Control of hormonal stress reactivity by the endogenous opioid system. | 1.46e-07 | 3 | 184 | 3 | 18280051 | |
| Pubmed | 1.46e-07 | 3 | 184 | 3 | 31110137 | ||
| Pubmed | SASH1 VPS50 NFASC CACHD1 BAP1 TAOK2 KMT2C DDX46 NUP155 INTS2 TNRC6A ANKIB1 ROBO2 ZMYM4 SEMA3E | 1.68e-07 | 529 | 184 | 15 | 14621295 | |
| Pubmed | DCAF1 STAM2 FLOT2 DMXL2 ANK3 USP11 PPFIBP1 MRPL44 CYP51A1 DCTN1 GTF3C3 NCAPG SF3B1 NUP155 SCD CLPTM1 AFG3L2 CDK5RAP1 COL14A1 CRYBG3 HERC2 CDC5L USP48 DDX24 CXADR | 3.45e-07 | 1487 | 184 | 25 | 33957083 | |
| Pubmed | DCAF1 FLOT2 TES ERCC6 ARID4B KDM5A USP11 VPS50 BRD3 SIN3A EZH1 ACTR6 AFG3L2 TNRC6A STK39 TTC39A CRYBG3 DDX24 PHIP TOP2A HDAC1 | 5.47e-07 | 1116 | 184 | 21 | 31753913 | |
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 17467916 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 7631421 | ||
| Pubmed | 5.80e-07 | 4 | 184 | 3 | 11724816 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | ARID4B KDM5A USP11 COP1 DARS1 SIN3A CPS1 DCTN1 GTF3C3 BAP1 KANSL2 NCAPG SF3B1 NFYA CCDC15 DDX24 TOP2A ZMYM4 | 7.94e-07 | 857 | 184 | 18 | 25609649 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 ERCC6 USP11 PSMC2 DARS1 VPS26A URB2 MCM10 DCTN1 GTF3C3 NCAPG SF3B1 NUP155 UFD1 EHD1 AFG3L2 ANKIB1 PRKDC HERC2 CDC5L DDX24 PHIP TOP2A | 8.80e-07 | 1353 | 184 | 23 | 29467282 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ARID4B KDM5A BRD3 SIN3A ARHGAP35 SF1 BAP1 OSBP KANSL2 DDX46 SF3B1 TAOK1 PRKDC DDX24 TOP2A ZMYM4 CXADR | 8.90e-07 | 774 | 184 | 17 | 15302935 |
| Pubmed | FLOT2 DMXL2 UBE2Q1 PPFIBP1 PSMC2 MCM10 ARHGAP35 CALML5 CLHC1 LPIN1 KMT2C EHD1 ROBO2 TAOK1 USP48 TBCD | 9.21e-07 | 689 | 184 | 16 | 36543142 | |
| Pubmed | DMXL2 ANK3 NRCAM KDM5A NFASC DCTN1 EHD3 TAOK2 NLGN3 SF3B1 TRIM67 PTPRD KCNJ4 PABPC3 DOCK7 PPP1R9B HERC2 CDC5L CDH2 | 9.81e-07 | 963 | 184 | 19 | 28671696 | |
| Pubmed | 1.07e-06 | 195 | 184 | 9 | 19454010 | ||
| Pubmed | 1.17e-06 | 64 | 184 | 6 | 22865885 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | BRD3 SIN3A DCTN1 GTF3C3 NCAPG ACTR6 PRKDC CDC5L USP48 DDX24 TOP2A HDAC1 | 1.44e-06 | 394 | 184 | 12 | 27248496 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 1.46e-06 | 150 | 184 | 8 | 28242625 | |
| Pubmed | USP11 MRPL44 VPS50 CYP51A1 PSMC2 SIN3A NCAPG NUP155 AFG3L2 SUGP1 DDX24 TOP2A TBCD HDAC1 | 1.94e-06 | 560 | 184 | 14 | 35241646 | |
| Pubmed | CDC42BPG NRDE2 DMXL2 PPFIBP1 SIN3A LPIN1 NUP155 AFG3L2 NEMF DOCK7 ANKIB1 CDK5RAP1 CRYBG3 TOP3A SEMA3E | 2.20e-06 | 650 | 184 | 15 | 38777146 | |
| Pubmed | FLOT2 ARID4B KDM5A USP11 MRPL44 PSMC2 COP1 DARS1 SIN3A CALML5 GTF3C3 BAP1 KMT2C KANSL2 ACTR6 PABPC3 TNRC6A NFYA SUGP1 HERC2 DOT1L DDX24 ZMYM4 | 2.21e-06 | 1429 | 184 | 23 | 35140242 | |
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 24748658 | ||
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 20188654 | ||
| Pubmed | 2.88e-06 | 6 | 184 | 3 | 33181265 | ||
| Pubmed | Expression of opioid receptors and ligands in pregnant mouse uterus and placenta. | 2.88e-06 | 6 | 184 | 3 | 9746745 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.89e-06 | 220 | 184 | 9 | 35785414 | |
| Pubmed | Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes? | 3.72e-06 | 170 | 184 | 8 | 23314748 | |
| Pubmed | 5.02e-06 | 7 | 184 | 3 | 17226765 | ||
| Pubmed | NRDE2 STARD8 ANK3 UBE2Q1 C5orf63 SALL4 TACC2 DCTN1 EHD3 KMT2C NLGN3 INTS2 SPIN1 SCD SOCS5 TAOK1 BOD1L1 DOT1L POLK | 5.45e-06 | 1084 | 184 | 19 | 11544199 | |
| Pubmed | STAM2 FLOT2 ANK3 PPFIBP1 PSMC2 DARS1 CACHD1 NUP155 EHD1 AFG3L2 DOCK7 BOD1L1 PRKDC CRYBG3 HDAC1 | 6.17e-06 | 708 | 184 | 15 | 39231216 | |
| Pubmed | Identification and characterization of three new components of the mSin3A corepressor complex. | 8.00e-06 | 8 | 184 | 3 | 12724404 | |
| Pubmed | 8.00e-06 | 8 | 184 | 3 | 15148359 | ||
| Pubmed | Vpr-binding protein antagonizes p53-mediated transcription via direct interaction with H3 tail. | 8.00e-06 | 8 | 184 | 3 | 22184063 | |
| Pubmed | Preimplantation mouse embryo is a target for opioid ligand-receptor signaling. | 8.00e-06 | 8 | 184 | 3 | 24855103 | |
| Pubmed | STAM2 USP11 VPS50 NAA10 BARD1 PSMC2 MCL1 DDX46 SCD UFD1 HERC2 USP48 | 1.09e-05 | 481 | 184 | 12 | 28190767 | |
| Pubmed | 1.20e-05 | 9 | 184 | 3 | 25653379 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | FLOT2 COP1 SALL4 SIN3A CPS1 SF3B1 PRKDC CDC5L TOP2A ZMYM4 HDAC1 | 1.34e-05 | 411 | 184 | 11 | 35182466 |
| Pubmed | 1.45e-05 | 339 | 184 | 10 | 30415952 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | UBE2Q1 PSMC2 DCTN1 NCAPG DDX46 SF3B1 NUP155 EHD1 TAOK1 PRKDC CDC5L USP48 TOP2A | 1.51e-05 | 582 | 184 | 13 | 20467437 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | ERCC6 MYH13 ANK3 VPS50 PCDHB9 BRD3 KMT2C DDX46 AFG3L2 RBM46 TAOK1 DDX24 | 1.51e-05 | 497 | 184 | 12 | 36774506 |
| Pubmed | 1.59e-05 | 272 | 184 | 9 | 31010829 | ||
| Pubmed | Motor neuron position and topographic order imposed by β- and γ-catenin activities. | 1.62e-05 | 29 | 184 | 4 | 22036570 | |
| Pubmed | STAM2 FLOT2 SASH1 ANK3 PPFIBP1 CACHD1 NUP155 AFG3L2 ROBO2 CDH2 CXADR | 1.67e-05 | 421 | 184 | 11 | 36976175 | |
| Pubmed | 1.69e-05 | 60 | 184 | 5 | 20682791 | ||
| Pubmed | TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. | 1.70e-05 | 10 | 184 | 3 | 21490601 | |
| Pubmed | Diversity of the cadherin family: evidence for eight new cadherins in nervous tissue. | 1.70e-05 | 10 | 184 | 3 | 2059658 | |
| Pubmed | 1.77e-05 | 347 | 184 | 10 | 16033648 | ||
| Pubmed | DCAF1 MYH3 ANK3 CDHR2 PENK MIF4GD ACVR2B CPS1 ADCY7 TAOK2 LPIN1 KMT2C NLGN3 NFE2L2 KDR RPGR USP48 FYB1 TNXB LMNTD1 | 1.88e-05 | 1293 | 184 | 20 | 15342556 | |
| Pubmed | BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. | 2.13e-05 | 31 | 184 | 4 | 23086144 | |
| Pubmed | 2.13e-05 | 31 | 184 | 4 | 26678539 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | DCAF1 CYP51A1 PSMC2 SIN3A URB2 MCM10 CALML5 SF1 GTF3C3 SF3B1 UFD1 SUGP1 BOD1L1 PRKDC CDC5L DDX24 TOP2A | 2.23e-05 | 989 | 184 | 17 | 36424410 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 2.31e-05 | 358 | 184 | 10 | 32460013 | |
| Pubmed | 2.33e-05 | 11 | 184 | 3 | 29263092 | ||
| Pubmed | The endocytic recycling regulatory protein EHD1 Is required for ocular lens development. | 2.33e-05 | 11 | 184 | 3 | 26455409 | |
| Pubmed | 2.33e-05 | 11 | 184 | 3 | 25189618 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | FLOT2 PCLO MRPL44 DARS1 URB2 CALML5 DCTN1 SF1 GTF3C3 NCAPG SF3B1 NUP155 NEMF DOCK7 BOD1L1 PRKDC CDC5L DDX24 PHIP TOP2A HDAC1 | 2.35e-05 | 1425 | 184 | 21 | 30948266 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | KDM5A NAA10 PSMC2 DARS1 VPS26A SF1 BAP1 NCAPG DDX46 SF3B1 SCD AFG3L2 TNRC6A TAOK1 PRKDC CDC5L DDX24 PHIP TOP2A HDAC1 | 2.47e-05 | 1318 | 184 | 20 | 30463901 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | DCAF1 USP11 BARD1 PSMC2 CALML5 BAP1 NUP155 UFD1 AFG3L2 DOCK7 PPP1R9B HERC2 CTSB USP48 DDX24 LSM7 ZMYM4 | 2.73e-05 | 1005 | 184 | 17 | 19615732 |
| Pubmed | Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM. | 2.75e-05 | 33 | 184 | 4 | 26864203 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 18995834 | ||
| Pubmed | Interplay between DOT1L and HDAC1 regulates Leishmania donovani infection in human THP-1 cells. | 2.78e-05 | 2 | 184 | 2 | 39103111 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24012878 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 8140728 | ||
| Pubmed | Endothelial SCUBE2 Interacts With VEGFR2 and Regulates VEGF-Induced Angiogenesis. | 2.78e-05 | 2 | 184 | 2 | 27834687 | |
| Pubmed | Implication of human N-alpha-acetyltransferase 5 in cellular proliferation and carcinogenesis. | 2.78e-05 | 2 | 184 | 2 | 18794801 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22423360 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19997907 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 1639480 | ||
| Pubmed | Translocation of bacteria from the gastrointestinal tract in immunodeficient mice. | 2.78e-05 | 2 | 184 | 2 | 8709573 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 33057152 | ||
| Pubmed | The tight junction protein CAR regulates cardiac conduction and cell-cell communication. | 2.78e-05 | 2 | 184 | 2 | 18794341 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 8962121 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 31304633 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 7759618 | ||
| Pubmed | A small molecule NRF2 activator BC-1901S ameliorates inflammation through DCAF1/NRF2 axis. | 2.78e-05 | 2 | 184 | 2 | 32171724 | |
| Pubmed | Operant self-administration of ethanol in C57BL/6 mice lacking beta-endorphin and enkephalin. | 2.78e-05 | 2 | 184 | 2 | 15388297 | |
| Pubmed | The beneficial effect of blocking Kv1.3 in the psoriasiform SCID mouse model. | 2.78e-05 | 2 | 184 | 2 | 20739949 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 28830982 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 8418200 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22586266 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11924817 | ||
| Pubmed | Evaluation of three lines of immunodeficient mice for the study of spontaneous metastatic tumors. | 2.78e-05 | 2 | 184 | 2 | 10225324 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 29963618 | ||
| Pubmed | An immunocompromised murine model of chronic Bartonella infection. | 2.78e-05 | 2 | 184 | 2 | 20395436 | |
| Pubmed | COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer. | 2.78e-05 | 2 | 184 | 2 | 25884720 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 8922386 | ||
| Pubmed | CAR links hypoxia signaling to improved survival after myocardial infarction. | 2.78e-05 | 2 | 184 | 2 | 36941462 | |
| Pubmed | Nonspecific immune responses and mechanisms of resistance to Eimeria papillata infections in mice. | 2.78e-05 | 2 | 184 | 2 | 9234770 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 17392156 | ||
| Interaction | H3-3A interactions | DCAF1 ERCC6 ARID4B KDM5A BARD1 BRD3 SIN3A VPS26A MCM10 GTF3C3 KMT2C SF3B1 TRIM67 SPIN1 BOD1L1 PRKDC HERC2 DOT1L POLK USP48 PHIP TOP2A ZMYM4 HDAC1 | 6.77e-08 | 749 | 181 | 24 | int:H3-3A |
| Interaction | GATAD2A interactions | ERCC6 ARID4B SALL4 BRD3 SIN3A BAP1 TRIM67 TNRC6A SUGP1 DOT1L TOP2A HDAC1 | 9.05e-07 | 224 | 181 | 12 | int:GATAD2A |
| Interaction | HSP90AB1 interactions | DCAF1 DMXL2 TES ANK3 UBE2Q1 USP11 PSMC2 DARS1 CPS1 BAP1 JAK3 KMT2C DDX46 TRIM67 TINF2 AFG3L2 DOCK7 PPP1R9B BOD1L1 PRKDC CDC5L TNNT1 USP48 DDX24 HDAC1 | 1.69e-06 | 960 | 181 | 25 | int:HSP90AB1 |
| Interaction | MAGEA9 interactions | UBE2Q1 PSMC2 ZDBF2 MCM10 TAOK2 TRIM67 SUGP1 TAOK1 HERC2 DDX24 TOP2A | 2.95e-06 | 208 | 181 | 11 | int:MAGEA9 |
| Interaction | TUBB4B interactions | TES USP11 COP1 TACC2 SIN3A DCTN1 BAP1 NCAPG TRIM67 TINF2 PPP1R9B RPGR HERC2 CDC5L USP48 ZMYM4 TBCD HDAC1 | 3.18e-06 | 560 | 181 | 18 | int:TUBB4B |
| Interaction | H2BC3 interactions | ERCC6 BARD1 BRD3 SIN3A DCTN1 BAP1 KMT2C TRIM67 ACTR6 PRKDC CDC5L DOT1L USP48 DDX24 HDAC1 | 4.18e-06 | 406 | 181 | 15 | int:H2BC3 |
| Interaction | NBN interactions | 6.30e-06 | 183 | 181 | 10 | int:NBN | |
| Interaction | WRN interactions | 6.81e-06 | 110 | 181 | 8 | int:WRN | |
| Interaction | DDX46 interactions | UBE2Q1 PSMC2 SIN3A EZH1 BAP1 DDX46 SF3B1 TRIM67 HERC2 CDC5L DOT1L | 6.82e-06 | 227 | 181 | 11 | int:DDX46 |
| Interaction | RAD50 interactions | DCAF1 ERCC6 USP11 BARD1 COP1 BAP1 BMP1 OSBP TRIM67 TMEM132A CFAP161 CDC5L USP48 HDAC1 | 6.94e-06 | 371 | 181 | 14 | int:RAD50 |
| Interaction | MTA2 interactions | ERCC6 ARID4B USP11 BARD1 SALL4 SIN3A DCTN1 BAP1 NCAPG TRIM67 PABPC3 PRKDC DOT1L TOP2A HDAC1 | 9.54e-06 | 435 | 181 | 15 | int:MTA2 |
| Interaction | HDAC2 interactions | DCAF1 ERCC6 ARID4B KDM5A USP11 SALL4 SIN3A CPS1 DCTN1 SF1 BAP1 NCAPG TRIM67 NFE2L2 EHD1 SUGP1 CDK5RAP1 COL14A1 PRKDC HERC2 TOP2A HDAC1 | 1.09e-05 | 865 | 181 | 22 | int:HDAC2 |
| Interaction | MRE11 interactions | DCAF1 ERCC6 USP11 BARD1 BAP1 BMP1 TRIM67 TINF2 PRKDC CFAP161 CDC5L TOP2A | 1.16e-05 | 287 | 181 | 12 | int:MRE11 |
| Interaction | MECP2 interactions | VPS37C NRDE2 FLOT2 DMXL2 KDM5A MRPL44 CYP51A1 BRD3 SIN3A URB2 ARHGAP35 EZH1 SF1 GTF3C3 DDX46 SF3B1 TRIM67 SPIN1 NEMF DOCK7 SUGP1 PRKDC CDC5L DDX24 LSM7 TNXB TOP3A HDAC1 | 1.19e-05 | 1287 | 181 | 28 | int:MECP2 |
| Interaction | COPS4 interactions | DCAF1 ERCC6 COP1 BAP1 TRIM67 DOCK7 PPP1R9B BOD1L1 USP48 PHIP | 1.93e-05 | 208 | 181 | 10 | int:COPS4 |
| Interaction | H3C1 interactions | DCAF1 ERCC6 ARID4B ANK3 KDM5A BARD1 PSMC2 BRD3 SIN3A GTF3C3 KMT2C SF3B1 TRIM67 NFE2L2 PABPC3 PRKDC USP48 DDX24 PHIP TOP2A ZMYM4 HDAC1 | 2.03e-05 | 901 | 181 | 22 | int:H3C1 |
| Interaction | MDC1 interactions | BARD1 BRD3 SIN3A KANSL2 TRIM67 TINF2 AFG3L2 TNRC6A KDR BOD1L1 PRKDC HERC2 CDC5L DOT1L | 2.37e-05 | 414 | 181 | 14 | int:MDC1 |
| Interaction | HECTD1 interactions | ERCC6 ARID4B MRPL44 BARD1 DARS1 TACC2 SIN3A URB2 MCM10 DCTN1 GTF3C3 NCAPG DDX46 TRIM67 NUP155 NEMF PRKDC HERC2 CDC5L DDX24 CDH2 TOP2A HDAC1 | 2.59e-05 | 984 | 181 | 23 | int:HECTD1 |
| Interaction | TNPO2 interactions | 3.64e-05 | 224 | 181 | 10 | int:TNPO2 | |
| Interaction | UBQLN4 interactions | STAM2 MIF4GD PSMC2 VPS26A TRIM67 ZPR1 UFD1 ROBO2 CTSB ZMYM4 HDAC1 | 3.67e-05 | 272 | 181 | 11 | int:UBQLN4 |
| Interaction | FOXK2 interactions | ARID4B KDM5A BARD1 SIN3A GTF3C3 BAP1 KANSL2 SF3B1 TRIM67 HDAC1 | 3.78e-05 | 225 | 181 | 10 | int:FOXK2 |
| Interaction | BZW1 interactions | 4.24e-05 | 183 | 181 | 9 | int:BZW1 | |
| Interaction | PARP1 interactions | STAM2 ERCC6 ARID4B USP11 MRPL44 BARD1 BRD3 SIN3A URB2 SF1 GTF3C3 BAP1 NCAPG TRIM67 NFYA DOCK7 PRKDC CDC5L CTSB USP48 PHIP PIWIL3 TOP2A ZMYM4 TOP3A TBCD HDAC1 | 4.83e-05 | 1316 | 181 | 27 | int:PARP1 |
| Interaction | UBR4 interactions | TES ARID4B POMC SIN3A BAP1 DDX46 TRIM67 ERMAP BOD1L1 HERC2 CTSB HDAC1 | 5.14e-05 | 334 | 181 | 12 | int:UBR4 |
| Interaction | DBI interactions | 5.62e-05 | 46 | 181 | 5 | int:DBI | |
| Interaction | RNF4 interactions | LRRC8E DCAF1 FLOT2 USP11 GOLM2 CYP51A1 NFASC SIN3A URB2 CALML5 SF1 GTF3C3 P4HTM SF3B1 NUP155 INTS2 NFE2L2 SCD CLPTM1 AFG3L2 TMEM132A DOCK7 PRKDC CDH2 TOP2A ZMYM4 CXADR TBCD | 6.26e-05 | 1412 | 181 | 28 | int:RNF4 |
| Interaction | BAG5 interactions | LRRC8E NRCAM USP11 DARS1 SF1 BAP1 TRIM67 DOCK7 IFI44L CRYBG3 CDC5L CTSB | 6.28e-05 | 341 | 181 | 12 | int:BAG5 |
| Interaction | ACTL6A interactions | ARID4B SALL4 BRD3 SIN3A SF1 BAP1 TRIM67 ACTR6 PRKDC DOT1L HDAC1 | 6.35e-05 | 289 | 181 | 11 | int:ACTL6A |
| Interaction | MTMR1 interactions | 6.50e-05 | 111 | 181 | 7 | int:MTMR1 | |
| Interaction | SF3B6 interactions | 6.67e-05 | 194 | 181 | 9 | int:SF3B6 | |
| Interaction | ESD interactions | 6.75e-05 | 77 | 181 | 6 | int:ESD | |
| Interaction | CTNNA1 interactions | TES SASH1 ANK3 USP11 OSBP TRIM67 NUP155 AFG3L2 HERC2 CDC5L CDH2 CDH12 | 7.41e-05 | 347 | 181 | 12 | int:CTNNA1 |
| Interaction | COPS3 interactions | DCAF1 ERCC6 ARID4B COP1 BAP1 TRIM67 DOCK7 PPP1R9B PHIP HDAC1 | 7.71e-05 | 245 | 181 | 10 | int:COPS3 |
| Interaction | ELF4 interactions | 8.13e-05 | 115 | 181 | 7 | int:ELF4 | |
| Interaction | KPNA3 interactions | BARD1 COP1 BRD3 GTF3C3 BAP1 TRIM67 NFE2L2 BOD1L1 TOP2A HDAC1 | 8.53e-05 | 248 | 181 | 10 | int:KPNA3 |
| Interaction | EHD1 interactions | 8.88e-05 | 157 | 181 | 8 | int:EHD1 | |
| Interaction | LAMTOR1 interactions | STAM2 FLOT2 PPFIBP1 VPS50 PSMC2 CACHD1 BAP1 BNIP2 TRIM67 PTPRD EHD1 AFG3L2 TMEM132A PLEKHM3 RPGR CRYBG3 DDX24 CXADR | 9.27e-05 | 722 | 181 | 18 | int:LAMTOR1 |
| Interaction | NAA15 interactions | 9.28e-05 | 158 | 181 | 8 | int:NAA15 | |
| Interaction | SMARCA5 interactions | ERCC6 BRD3 SIN3A EHD3 NCAPG SF3B1 TRIM67 KDR PRKDC CDC5L DOT1L PHIP HDAC1 | 1.01e-04 | 415 | 181 | 13 | int:SMARCA5 |
| Interaction | MCM4 interactions | ANK3 VPS50 MCM10 DCTN1 BAP1 SF3B1 TRIM67 NEMF CDC5L POLK HDAC1 | 1.06e-04 | 306 | 181 | 11 | int:MCM4 |
| Interaction | RANBP2 interactions | TES ARID4B BAP1 TAOK2 SF3B1 TRIM67 SUGP1 PRKDC CDC5L DOT1L TOP2A HDAC1 | 1.08e-04 | 361 | 181 | 12 | int:RANBP2 |
| Interaction | SMC1A interactions | DCAF1 BARD1 PSMC2 GTF3C3 BAP1 SF3B1 TRIM67 NEMF PRKDC RPGR CDC5L DOT1L HDAC1 | 1.08e-04 | 418 | 181 | 13 | int:SMC1A |
| Interaction | TUBB interactions | TES USP11 PSMC2 COP1 BRD3 BAP1 TAOK2 TRIM67 TINF2 NFE2L2 CDK5RAP1 PPP1R9B RPGR CDC5L USP48 ZMYM4 TBCD HDAC1 | 1.16e-04 | 735 | 181 | 18 | int:TUBB |
| Interaction | SPTBN1 interactions | TES SASH1 ANK3 USP11 DCTN1 BAP1 TRIM67 PPP1R9B HERC2 CDC5L USP48 CDH2 PHIP | 1.16e-04 | 421 | 181 | 13 | int:SPTBN1 |
| Interaction | SEPTIN11 interactions | 1.18e-04 | 122 | 181 | 7 | int:SEPTIN11 | |
| Interaction | DDX41 interactions | 1.31e-04 | 166 | 181 | 8 | int:DDX41 | |
| Interaction | TXNIP interactions | 1.31e-04 | 212 | 181 | 9 | int:TXNIP | |
| Interaction | H2AZ1 interactions | ARID4B BRD3 SIN3A GTF3C3 TRIM67 ACTR6 PRKDC USP48 PHIP TOP2A ZMYM4 HDAC1 | 1.39e-04 | 371 | 181 | 12 | int:H2AZ1 |
| Interaction | BRCA1 interactions | ERCC6 USP11 BARD1 PSMC2 DARS1 MCM10 DCTN1 BAP1 SF3B1 NUP155 TINF2 NFE2L2 EHD1 TNRC6A NFYA PPP1R9B PRKDC HERC2 CDC5L USP48 DDX24 LMNTD1 TOP2A TOP3A HDAC1 | 1.40e-04 | 1249 | 181 | 25 | int:BRCA1 |
| Interaction | PPFIA1 interactions | 1.41e-04 | 214 | 181 | 9 | int:PPFIA1 | |
| Interaction | SNW1 interactions | UBE2Q1 PSMC2 SIN3A EZH1 DCTN1 SF1 NCAPG DDX46 SF3B1 TRIM67 NUP155 EHD1 TAOK1 PRKDC CDC5L DOT1L TNNT1 USP48 | 1.42e-04 | 747 | 181 | 18 | int:SNW1 |
| Interaction | ELF1 interactions | 1.44e-04 | 126 | 181 | 7 | int:ELF1 | |
| Interaction | ASH2L interactions | BARD1 SIN3A BAP1 KMT2C KANSL2 TRIM67 TNRC6A BOD1L1 DOT1L HDAC1 | 1.47e-04 | 265 | 181 | 10 | int:ASH2L |
| Interaction | CHD1 interactions | 1.52e-04 | 127 | 181 | 7 | int:CHD1 | |
| Interaction | YWHAE interactions | DCAF1 SASH1 PPFIBP1 TACC2 MCM10 DCTN1 LYST BAP1 TAOK2 LPIN1 SF3B1 TRIM67 ACTR6 SPIN1 ZPR1 DOCK7 PPP1R9B PLEKHM3 RPGR CDC5L DOT1L USP48 DDX24 TOP2A HDAC1 | 1.52e-04 | 1256 | 181 | 25 | int:YWHAE |
| Interaction | TACC1 interactions | 1.61e-04 | 171 | 181 | 8 | int:TACC1 | |
| Interaction | AURKB interactions | BARD1 PSMC2 SIN3A CPS1 DCTN1 GTF3C3 DDX46 SF3B1 TRIM67 PABPC3 DOCK7 PRKDC CRYBG3 HERC2 CDC5L USP48 DDX24 TOP2A | 1.78e-04 | 761 | 181 | 18 | int:AURKB |
| Interaction | UBXN6 interactions | CDC42BPG PPFIBP1 MCL1 GTF3C3 NLGN3 NCAPG TRIM67 UFD1 DOCK7 PRKDC CXADR | 1.79e-04 | 325 | 181 | 11 | int:UBXN6 |
| Interaction | THOC5 interactions | 1.84e-04 | 131 | 181 | 7 | int:THOC5 | |
| Interaction | TOP1 interactions | DCAF1 ERCC6 ARID4B BARD1 BRD3 GTF3C3 BAP1 SF3B1 TRIM67 INTS2 NFYA PRKDC HERC2 CDC5L TNNT1 DDX24 TOP2A | 1.86e-04 | 696 | 181 | 17 | int:TOP1 |
| Interaction | DUSP26 interactions | 1.87e-04 | 59 | 181 | 5 | int:DUSP26 | |
| Interaction | ERG interactions | 1.92e-04 | 223 | 181 | 9 | int:ERG | |
| Interaction | KIF20A interactions | FLOT2 NUP210L PPFIBP1 PCLO CPS1 DCTN1 SF1 LPIN1 DDX46 SF3B1 TRIM67 NUP155 PABPC3 TNRC6A PPP1R9B BOD1L1 PRKDC CRYBG3 HERC2 CDH9 TOP2A HDAC1 | 1.97e-04 | 1052 | 181 | 22 | int:KIF20A |
| Interaction | NR5A1 interactions | 2.02e-04 | 60 | 181 | 5 | int:NR5A1 | |
| Interaction | H1-1 interactions | DCAF1 USP11 PCLO MCL1 SF1 SF3B1 SCN4A PRKDC CDC5L DOT1L USP48 DDX24 ZMYM4 HDAC1 | 2.04e-04 | 507 | 181 | 14 | int:H1-1 |
| Interaction | RBBP7 interactions | ERCC6 ARID4B KDM5A USP11 SALL4 SIN3A EZH1 BAP1 NCAPG TRIM67 DOCK7 CDC5L DOT1L HDAC1 | 2.04e-04 | 507 | 181 | 14 | int:RBBP7 |
| Interaction | KIF15 interactions | 2.04e-04 | 94 | 181 | 6 | int:KIF15 | |
| Interaction | PLK1 interactions | DCAF1 ANK3 USP11 CALML5 DCTN1 GTF3C3 BNIP2 PTPRD NUP155 STK39 PRKDC CDC5L TOP2A CXADR | 2.17e-04 | 510 | 181 | 14 | int:PLK1 |
| Interaction | NSUN5 interactions | 2.19e-04 | 61 | 181 | 5 | int:NSUN5 | |
| Interaction | RFC4 interactions | 2.19e-04 | 227 | 181 | 9 | int:RFC4 | |
| Interaction | MTNR1B interactions | 2.21e-04 | 135 | 181 | 7 | int:MTNR1B | |
| Interaction | SINHCAF interactions | 2.21e-04 | 135 | 181 | 7 | int:SINHCAF | |
| Interaction | UNC45A interactions | 2.26e-04 | 228 | 181 | 9 | int:UNC45A | |
| Interaction | EED interactions | DCAF1 CDC42BPG NRDE2 FLOT2 ARID4B KDM5A PSMC2 DARS1 SALL4 SIN3A EZH1 DCTN1 SF1 GTF3C3 SF3B1 TRIM67 NUP155 EHD1 PPP1R9B PRKDC HERC2 CDC5L USP48 DDX24 TOP2A TBCD HDAC1 | 2.28e-04 | 1445 | 181 | 27 | int:EED |
| Interaction | SFSWAP interactions | 2.29e-04 | 96 | 181 | 6 | int:SFSWAP | |
| Interaction | TPR interactions | 2.36e-04 | 281 | 181 | 10 | int:TPR | |
| Interaction | SMC4 interactions | 2.36e-04 | 281 | 181 | 10 | int:SMC4 | |
| Interaction | PAXX interactions | 2.36e-04 | 34 | 181 | 4 | int:PAXX | |
| Interaction | SCP2D1 interactions | 2.39e-04 | 3 | 181 | 2 | int:SCP2D1 | |
| Interaction | VTA1 interactions | 2.42e-04 | 137 | 181 | 7 | int:VTA1 | |
| Interaction | YY1 interactions | ARID4B SIN3A EZH1 GTF3C3 BAP1 KANSL2 TRIM67 NFE2L2 ACTR6 PRKDC DOT1L ZMYM4 HDAC1 | 2.44e-04 | 454 | 181 | 13 | int:YY1 |
| Interaction | SF3B2 interactions | ERCC6 VPS50 SF1 BAP1 NCAPG DDX46 SF3B1 TRIM67 SUGP1 PRKDC CDC5L DOT1L TOP2A HDAC1 | 2.49e-04 | 517 | 181 | 14 | int:SF3B2 |
| Interaction | MTA1 interactions | 2.50e-04 | 283 | 181 | 10 | int:MTA1 | |
| Interaction | CORO1C interactions | TES ERCC6 USP11 VPS26A BAP1 TRIM67 PPP1R9B HERC2 DOT1L USP48 DNAH6 | 2.51e-04 | 338 | 181 | 11 | int:CORO1C |
| Interaction | UBE2Q1 interactions | 2.55e-04 | 63 | 181 | 5 | int:UBE2Q1 | |
| Interaction | LIMS1 interactions | 2.57e-04 | 98 | 181 | 6 | int:LIMS1 | |
| Interaction | BUB3 interactions | 2.58e-04 | 232 | 181 | 9 | int:BUB3 | |
| Interaction | KPNA2 interactions | USP11 COP1 DCTN1 BAP1 NCAPG SF3B1 TRIM67 NUP155 NFE2L2 ANKIB1 BOD1L1 CDC5L DOT1L HDAC1 | 2.59e-04 | 519 | 181 | 14 | int:KPNA2 |
| Interaction | MACROH2A1 interactions | DCAF1 BARD1 COP1 BRD3 SIN3A GTF3C3 TRIM67 PPP1R9B KDR CDC5L USP48 TOP2A HDAC1 | 2.65e-04 | 458 | 181 | 13 | int:MACROH2A1 |
| Interaction | MYO6 interactions | DCAF1 FLOT2 USP11 DCTN1 BAP1 BNIP2 TRIM67 DOCK7 PPP1R9B CTSB USP48 TOP2A | 2.65e-04 | 398 | 181 | 12 | int:MYO6 |
| Interaction | U2AF2 interactions | FLOT2 BARD1 PSMC2 DARS1 BRD3 SF1 BAP1 NCAPG DDX46 SF3B1 TRIM67 SUGP1 PRKDC HERC2 CDC5L HDAC1 | 2.70e-04 | 651 | 181 | 16 | int:U2AF2 |
| Interaction | MCM6 interactions | 2.79e-04 | 287 | 181 | 10 | int:MCM6 | |
| Interaction | RBBP5 interactions | SIN3A KMT2C KANSL2 TRIM67 TNRC6A BOD1L1 CDC5L POLK TOP2A HDAC1 | 2.79e-04 | 287 | 181 | 10 | int:RBBP5 |
| Interaction | CEP250 interactions | DCAF1 PPFIBP1 GTF3C3 TRIM67 TNRC6A DOCK7 ANKIB1 HERC2 DDX24 HDAC1 | 2.79e-04 | 287 | 181 | 10 | int:CEP250 |
| Interaction | RBMX interactions | ERCC6 COP1 CACHD1 SF1 OSBP SF3B1 TRIM67 NFE2L2 PPP1R9B PRKDC CDC5L USP48 TOP2A | 2.82e-04 | 461 | 181 | 13 | int:RBMX |
| Interaction | PML interactions | TES ERCC6 USP11 COP1 TACC2 SIN3A MCM10 SF1 GTF3C3 NCAPG DDX46 TRIM67 SUGP1 STK39 CDC5L POLK PHIP TOP2A ZMYM4 HDAC1 | 2.84e-04 | 933 | 181 | 20 | int:PML |
| Interaction | SMARCA4 interactions | ERCC6 ARID4B SALL4 BRD3 SIN3A GTF3C3 TRIM67 NFE2L2 CDC5L DOT1L PHIP TOP2A HDAC1 | 2.88e-04 | 462 | 181 | 13 | int:SMARCA4 |
| Interaction | COPS7B interactions | 2.89e-04 | 141 | 181 | 7 | int:COPS7B | |
| Interaction | MATR3 interactions | USP11 VPS50 DCTN1 BAP1 NCAPG SF3B1 TRIM67 CDK5RAP1 PPP1R9B PRKDC HERC2 CDC5L DOT1L USP48 ZMYM4 HDAC1 | 2.89e-04 | 655 | 181 | 16 | int:MATR3 |
| Interaction | ME1 interactions | 2.95e-04 | 65 | 181 | 5 | int:ME1 | |
| GeneFamily | Fibronectin type III domain containing | 3.02e-06 | 160 | 134 | 9 | 555 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 8.34e-05 | 12 | 134 | 3 | 1243 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.99e-04 | 161 | 134 | 7 | 593 | |
| GeneFamily | Bone morphogenetic proteins|Astacins | 8.02e-04 | 6 | 134 | 2 | 894 | |
| GeneFamily | Topoisomerases | 8.02e-04 | 6 | 134 | 2 | 1050 | |
| GeneFamily | SH2 domain containing|Suppressors of cytokine signaling | 1.48e-03 | 8 | 134 | 2 | 764 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 1.90e-03 | 9 | 134 | 2 | 1230 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 1.90e-03 | 9 | 134 | 2 | 1306 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.01e-03 | 34 | 134 | 3 | 487 | |
| GeneFamily | N(alpha)-acetyltransferase subunits|GCN5 related N-acetyltransferases | 3.43e-03 | 12 | 134 | 2 | 660 | |
| GeneFamily | CD molecules|Type II classical cadherins | 4.03e-03 | 13 | 134 | 2 | 1186 | |
| GeneFamily | BCL2 family | 4.68e-03 | 14 | 134 | 2 | 1057 | |
| GeneFamily | AT-rich interaction domain containing | 5.37e-03 | 15 | 134 | 2 | 418 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 5.37e-03 | 15 | 134 | 2 | 26 | |
| GeneFamily | Myosin heavy chains | 5.37e-03 | 15 | 134 | 2 | 1098 | |
| Coexpression | AFFAR_YY1_TARGETS_UP | 1.47e-06 | 199 | 183 | 10 | M1466 | |
| Coexpression | GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN | GTF3C3 JAK3 OSBP CACNA2D4 NFE2L2 AFG3L2 NEMF SUGP1 CDH2 ZMYM4 | 1.54e-06 | 200 | 183 | 10 | M6372 |
| Coexpression | AFFAR_YY1_TARGETS_UP | 3.20e-06 | 217 | 183 | 10 | MM1156 | |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | ABAT CYP51A1 PSMC2 VPS26A LYST PTGS1 SCD NAA20 ANKIB1 STK39 RPGR TOP2A | 1.56e-05 | 379 | 183 | 12 | M1885 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | MGAM PENK PCDHB9 PPP1R14A ETV1 ADCY7 SEC14L3 KMT2C NCAPG SF3B1 SCD TNRC6A RBM46 COL14A1 KDR TAOK1 STK39 TNNT1 TNXB PLTP TOP2A | 4.45e-06 | 799 | 180 | 21 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | USP11 CYP51A1 PPP1R14A ZDBF2 CACHD1 BMP1 NCAPG PTPRD ACTR6 SCD ROBO2 COL14A1 PPP1R9B KDR STK39 CFAP161 TNNT1 CDH2 TOP2A SEMA3E | 2.54e-05 | 827 | 180 | 20 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_200 | 4.65e-05 | 24 | 180 | 4 | gudmap_developingGonad_e12.5_ovary_k5_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | DCAF1 DMXL2 ERCC6 VPS50 ETV1 BARD1 SALL4 SIN3A URB2 MCM10 GTF3C3 NCAPG ACTR6 CDK5RAP1 RBM46 PRKDC PNPLA7 TNNT1 FYB1 | 6.14e-05 | 810 | 180 | 19 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | DCAF1 DMXL2 ERCC6 KDM5A VPS50 PENK BARD1 DARS1 SALL4 VPS26A URB2 LYST KMT2C NCAPG SUGP1 CDK5RAP1 RBM46 PRKDC RPGR | 7.23e-05 | 820 | 180 | 19 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | DMXL2 KDM5A PCDHB9 EZH1 KMT2C NCAPG SF3B1 SCUBE2 INTS2 ACTR6 SCD ASPA TNRC6A ANKIB1 RBM46 TAOK1 STK39 RPGR | 1.15e-04 | 778 | 180 | 18 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | ABAT ANK3 RIMKLA PPFIBP1 GOLM2 PCDHB9 MCM10 ACVR2B EZH1 NCAPG NUP155 INTS2 SOCS4 NEMF SLC9B2 CNTN3 ROBO2 CDH2 | 1.17e-04 | 779 | 180 | 18 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | MGAM PENK PCDHB9 ADCY7 BMP1 KMT2C NCAPG SF3B1 SCD TNRC6A ROBO2 RBM46 COL14A1 KDR TAOK1 STK39 PLTP TOP2A | 1.39e-04 | 790 | 180 | 18 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | DCAF1 DMXL2 VPS50 ETV1 BARD1 DARS1 SALL4 SIN3A VPS26A URB2 MCM10 GTF3C3 NCAPG ACTR6 CDK5RAP1 RBM46 PRKDC FYB1 | 1.50e-04 | 795 | 180 | 18 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.58e-04 | 230 | 180 | 9 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-06 | 195 | 184 | 8 | cbe518b465b4ef32797ae6b608219207c08493df | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-06 | 195 | 184 | 8 | 136b06b0931a69b1241101f68c01c44c70365fd9 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.70e-06 | 197 | 184 | 8 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.76e-06 | 198 | 184 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.76e-06 | 198 | 184 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.90e-06 | 200 | 184 | 8 | 65c83a3f6ee2a10bcb5b95076696232c6373a7b4 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.90e-06 | 200 | 184 | 8 | 40e969883bc302e8fbc6b6ab9814529dc1472902 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.90e-06 | 200 | 184 | 8 | ad9cdc82a647d379abc713a56db0e11bb6494106 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.90e-06 | 200 | 184 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.10e-06 | 162 | 184 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 9.10e-06 | 177 | 184 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 184 | 184 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 184 | 184 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-05 | 184 | 184 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 186 | 184 | 7 | cd6502bbf9dce318fdbb4965d49df8951e5f795c | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.26e-05 | 186 | 184 | 7 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-05 | 186 | 184 | 7 | b58db5abdd3e9f0214b198c3cbd09b0b3c321eab | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.35e-05 | 188 | 184 | 7 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | Fibroblast-A|World / shred on cell class and cell subclass (v4) | 1.35e-05 | 188 | 184 | 7 | 6740bed5fb8f45b6eea17041894b804214c2a4ae | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.39e-05 | 189 | 184 | 7 | 3169476f98b7385706cb618c9ad64ae83a290ef0 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 1.44e-05 | 190 | 184 | 7 | 6e92c78799f34b31d098854503c796edb0dc7f80 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 1.49e-05 | 191 | 184 | 7 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | 11.5-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 1.49e-05 | 191 | 184 | 7 | c1bb3ae5c297f55cdadf5b6e53d5296389d5099e | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 1.54e-05 | 192 | 184 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-05 | 196 | 184 | 7 | 14246f00c90741a5f8683f377e22e3a7c99661b9 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 1.76e-05 | 196 | 184 | 7 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-05 | 196 | 184 | 7 | f068ce40bf35021baf1468ae9ce30a92162eb14d | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-05 | 196 | 184 | 7 | 2a885eed52f9b002c7995e11e450c7e8d7ae69e6 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 197 | 184 | 7 | 7b12f9d4ad1e84df58e86591a491c84d4f36eac5 | |
| ToppCell | facs-Brain_Non-Myeloid|facs / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-05 | 197 | 184 | 7 | a1f7eec1aca03432caa8fe817ff6d24b29d4062d | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.82e-05 | 197 | 184 | 7 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-05 | 198 | 184 | 7 | 97ae237f955fd5fbd01d06aafe89ef9e6f777a9a | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-05 | 199 | 184 | 7 | 2cec0e370ee9bb3c88a7acb5519e9ea8ddb399bc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.94e-05 | 199 | 184 | 7 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.94e-05 | 199 | 184 | 7 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.94e-05 | 199 | 184 | 7 | 9e87b64e16d595701c3beb07aa835afe3330bd10 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-05 | 200 | 184 | 7 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.01e-05 | 200 | 184 | 7 | 410b1a31de21c57d87ca2104f61cf4a7d4dd2f30 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma|TCGA-Liver / Sample_Type by Project: Shred V9 | 2.01e-05 | 200 | 184 | 7 | bc7aba2885ca1093fcd884807b497700dae4835e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 2.01e-05 | 200 | 184 | 7 | 09fd3cb31bcc02444f1045f01fe39bce09359d35 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 2.01e-05 | 200 | 184 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.90e-05 | 143 | 184 | 6 | cc396b81a5e47d78c2d1cb49d682391376b63476 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.90e-05 | 143 | 184 | 6 | 24fd24846fbef049af669a57d42fcc18928d2b27 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.23e-05 | 153 | 184 | 6 | c1335e7d7407412431ed4d8c7dfcb2c6086d8483 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.81e-05 | 162 | 184 | 6 | d0d9c18a73bc0bf4f38308ef2eee8ae20f6a7918 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.81e-05 | 162 | 184 | 6 | 80619a93c57fe16daf91dc571874ef9ac888953d | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.81e-05 | 162 | 184 | 6 | 06f5d6c0bb26fe9d5180bc2ebf2c54bf52e715f3 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral_and_Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.44e-05 | 165 | 184 | 6 | d449a568664a81d9b5538e8f409301448a32ac37 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.88e-05 | 167 | 184 | 6 | 5accd0bc7c95089feb2c09376d12cd8bd3773775 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.88e-05 | 167 | 184 | 6 | 40d102e01ccbc7262d00fafd59ca5234909009cb | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.11e-05 | 168 | 184 | 6 | 8f0c4dfad9f6fed9dcc31795abfe77758ceb46a1 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 168 | 184 | 6 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_ETV4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.35e-05 | 169 | 184 | 6 | 716e9d4c5fb99c56b76afaa5ed90bfa859fde802 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.35e-05 | 169 | 184 | 6 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.51e-05 | 105 | 184 | 5 | 8d5528ae2bdba17e2474a7ca07fc8596d1b04647 | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.59e-05 | 170 | 184 | 6 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-prox-progenitor-MUC5AC+ASCL1+_intermediate_|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.59e-05 | 170 | 184 | 6 | d6e244725b21592c6056b9c443aac090f1eae836 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-05 | 170 | 184 | 6 | dd48fd3c5c67eb71183981f42975a538f12077c3 | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.36e-05 | 173 | 184 | 6 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.63e-05 | 174 | 184 | 6 | 7d4b860e05b5931f6f9d757a68f75ff35597a47a | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 9.19e-05 | 176 | 184 | 6 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | 5'-Adult-Distal_Rectal-Epithelial-goblet-Goblet_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.48e-05 | 177 | 184 | 6 | e1e45956887371b1c18f1eb479dd930031497520 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Basal/Suprabasal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.48e-05 | 177 | 184 | 6 | cbad1a23851151dbef01ea2af960e6f0944f838b | |
| ToppCell | facs-Lung-nan-3m-Epithelial-club_cell_of_bronchiole|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-05 | 177 | 184 | 6 | e5070934c674a46e070b0d52b9a374516bf6aea1 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Club_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.48e-05 | 177 | 184 | 6 | b37d821f4f3204daf7c568ac17a0af0ba97273d6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 179 | 184 | 6 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | E15.5-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-04 | 179 | 184 | 6 | b559f5a72cc9e3e35d05cb539b5c2e006e56e652 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.04e-04 | 180 | 184 | 6 | 1363b3254470f6ff98630d1df83a1bdbacc137e0 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Lymphocytic-T_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 180 | 184 | 6 | 87347af8f28cf7c486c19f3f98c0afb022c323b5 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.04e-04 | 180 | 184 | 6 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 181 | 184 | 6 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 181 | 184 | 6 | cb17c904ab86d56dd30cac9b61acbb3b76f84ded | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 181 | 184 | 6 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Macroglial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 182 | 184 | 6 | 0beffe6b9b36cfd196ec98a18f6ded080c162f90 | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.17e-04 | 184 | 184 | 6 | 924400f47e6b2cdf7b0d538df75857935cf0209b | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.17e-04 | 184 | 184 | 6 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 184 | 184 | 6 | 0ba243cbf69b4fe6ae100a7f0314317bec38026c | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.17e-04 | 184 | 184 | 6 | 2a8338e94937686a148b5433515700ca0f674058 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 184 | 184 | 6 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-04 | 185 | 184 | 6 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.21e-04 | 185 | 184 | 6 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.21e-04 | 185 | 184 | 6 | 847257d232b9993cad50c814fd4ffeef52385295 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 186 | 184 | 6 | f73cb91e74a806858650ae97f543fc779ba4cff8 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.24e-04 | 186 | 184 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.24e-04 | 186 | 184 | 6 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l30|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-04 | 187 | 184 | 6 | 6f7f293c9cf35261e0e3614e46ec1fb00a701b63 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-04 | 187 | 184 | 6 | 8bd635abdee5d5a12a3f7bf74eab4282e8e40741 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.28e-04 | 187 | 184 | 6 | 3cb8cd7f7a4306ff74d1f7f9964014008ec1c6a0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.28e-04 | 187 | 184 | 6 | 2a7226adb4d15b92936603bdf05421c50b21f003 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 187 | 184 | 6 | 11670a85db87cbb3e78022a589632173604b0940 | |
| ToppCell | Tuft-tuft-2|World / Class top | 1.28e-04 | 187 | 184 | 6 | 4ec6eee866619dfe13c84f5d2e812bb380d37139 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-E_(AT2)|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.28e-04 | 187 | 184 | 6 | 0277d4e54bd4d48f30241c2951a569209423fee8 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 188 | 184 | 6 | 1526e271411e381eae7a342003002276f83f47a3 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 1.32e-04 | 188 | 184 | 6 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_A_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 189 | 184 | 6 | ce3fbaf9642785c8adf6edaeae20998bca558928 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 189 | 184 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 189 | 184 | 6 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 189 | 184 | 6 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 1.36e-04 | 189 | 184 | 6 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | 343B-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 189 | 184 | 6 | c26428871dc3261327d89cacaba6e21e004ff1f3 | |
| Drug | 1-(2-((1-ethoxycarbonyloxyethoxycarbonylmethyl)carbamoyl)-3-phenylpropyldisulfanylmethyl)-3-methylsulfanylpropylamine | 5.19e-07 | 3 | 184 | 3 | ctd:C534222 | |
| Drug | N-methylnaloxone | 5.19e-07 | 3 | 184 | 3 | ctd:C041269 | |
| Drug | Guanyl-damme | 2.06e-06 | 4 | 184 | 3 | CID005487604 | |
| Drug | 4-chloroaniline | MGAM MYH3 FLOT2 MYH13 PPP1R14A ETV1 SEZ6L2 NFE2L2 ACTR6 TNNT1 | 6.06e-06 | 202 | 184 | 10 | CID000007812 |
| Drug | pyridostigmine | 1.06e-05 | 93 | 184 | 7 | CID000004991 | |
| Drug | 17-DMAG; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.72e-05 | 181 | 184 | 9 | 5573_UP | |
| Drug | RB 38A | 1.77e-05 | 7 | 184 | 3 | CID000129130 | |
| Drug | Phorphin | 1.77e-05 | 7 | 184 | 3 | CID000145939 | |
| Disease | Autistic Disorder | 4.80e-06 | 261 | 179 | 10 | C0004352 | |
| Disease | Adenocarcinoma of lung (disorder) | 5.04e-06 | 206 | 179 | 9 | C0152013 | |
| Disease | Hypoventilation | 3.66e-05 | 2 | 179 | 2 | C3203358 | |
| Disease | salivary gland carcinoma (is_marker_for) | 3.66e-05 | 2 | 179 | 2 | DOID:0050904 (is_marker_for) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 6.00e-05 | 13 | 179 | 3 | DOID:397 (implicated_via_orthology) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 6.12e-05 | 111 | 179 | 6 | EFO_0004530, EFO_0008595 | |
| Disease | platelet component distribution width | STARD8 MYH13 NUP210L BRD3 SIN3A CPS1 EHD3 SEC14L3 ZPR1 DOCK7 SUGP1 PPP1R9B POLK FYB1 TNXB | 6.18e-05 | 755 | 179 | 15 | EFO_0007984 |
| Disease | phosphatidylcholine measurement | 6.37e-05 | 284 | 179 | 9 | EFO_0010226 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 7.25e-05 | 166 | 179 | 7 | EFO_0004530, EFO_0004611 | |
| Disease | Colorectal Carcinoma | STARD8 ERCC6 NRCAM PPP1R14A ETV1 LPIN1 KMT2C OSBP NCAPG PTPRD ABCB11 KDR PHIP ZMYM4 | 1.05e-04 | 702 | 179 | 14 | C0009402 |
| Disease | semaphorin-3E measurement | 1.09e-04 | 3 | 179 | 2 | EFO_0008279 | |
| Disease | Familial vesicoureteral reflux | 1.09e-04 | 3 | 179 | 2 | cv:C4706552 | |
| Disease | Familial vesicoureteral reflux | 1.09e-04 | 3 | 179 | 2 | C4706552 | |
| Disease | Vesicoureteral reflux | 1.09e-04 | 3 | 179 | 2 | cv:C0042580 | |
| Disease | triacylglycerol 50:5 measurement | 1.16e-04 | 16 | 179 | 3 | EFO_0010412 | |
| Disease | C-reactive protein measurement | PMS2P3 DMXL2 CFAP251 TES ANK3 UBE2Q1 NUP210L BRD3 CACHD1 NFE2L2 ZPR1 SCN4A CLPTM1 DOCK7 ABCB11 CTSB FYB1 RAB26 PLTP | 1.44e-04 | 1206 | 179 | 19 | EFO_0004458 |
| Disease | choline measurement | 1.47e-04 | 130 | 179 | 6 | EFO_0010116 | |
| Disease | Global developmental delay | 1.66e-04 | 133 | 179 | 6 | C0557874 | |
| Disease | free cholesterol in very small VLDL measurement | 1.91e-04 | 47 | 179 | 4 | EFO_0022275 | |
| Disease | heroin dependence (implicated_via_orthology) | 2.18e-04 | 4 | 179 | 2 | DOID:9976 (implicated_via_orthology) | |
| Disease | Vesico-Ureteral Reflux | 2.18e-04 | 4 | 179 | 2 | C0042580 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 2.18e-04 | 4 | 179 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | phospholipid measurement | 2.20e-04 | 140 | 179 | 6 | EFO_0004639 | |
| Disease | Arthrogryposis | 2.69e-04 | 21 | 179 | 3 | C0003886 | |
| Disease | Malignant melanoma of iris | 3.62e-04 | 5 | 179 | 2 | C0346373 | |
| Disease | Malignant melanoma of choroid | 3.62e-04 | 5 | 179 | 2 | C0346388 | |
| Disease | Restless Legs Syndrome | 3.62e-04 | 5 | 179 | 2 | C0035258 | |
| Disease | vesicoureteral reflux (is_implicated_in) | 3.62e-04 | 5 | 179 | 2 | DOID:9620 (is_implicated_in) | |
| Disease | Duane Retraction Syndrome | 3.62e-04 | 5 | 179 | 2 | C0013261 | |
| Disease | triglycerides in very large VLDL measurement | 3.76e-04 | 56 | 179 | 4 | EFO_0022325 | |
| Disease | triglycerides to total lipids in medium HDL percentage | 3.76e-04 | 56 | 179 | 4 | EFO_0022333 | |
| Disease | Intrahepatic Cholangiocarcinoma | 4.05e-04 | 24 | 179 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 4.05e-04 | 24 | 179 | 3 | C3805278 | |
| Disease | Prostatic Neoplasms | PENK ETV1 BAP1 KMT2C SF3B1 NFE2L2 ROBO2 PRKDC POLK CTSB TOP2A CDH12 | 4.05e-04 | 616 | 179 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | PENK ETV1 BAP1 KMT2C SF3B1 NFE2L2 ROBO2 PRKDC POLK CTSB TOP2A CDH12 | 4.05e-04 | 616 | 179 | 12 | C0376358 |
| Disease | Intellectual Disability | 4.28e-04 | 447 | 179 | 10 | C3714756 | |
| Disease | triglycerides in VLDL measurement | 4.59e-04 | 59 | 179 | 4 | EFO_0022326 | |
| Disease | cholesterol to total lipids in medium HDL percentage | 4.90e-04 | 60 | 179 | 4 | EFO_0022237 | |
| Disease | mean platelet volume | CFAP251 STARD8 NUP210L PCDHGA3 NFASC BRD3 SIN3A CPS1 EHD3 SCD ZPR1 TNRC6A DOCK7 TAOK1 PHIP TBCD | 5.12e-04 | 1020 | 179 | 16 | EFO_0004584 |
| Disease | Cholangiocarcinoma | 5.15e-04 | 26 | 179 | 3 | C0206698 | |
| Disease | triglycerides in small VLDL measurement | 5.22e-04 | 61 | 179 | 4 | EFO_0022145 | |
| Disease | 1-stearoyl-2-linoleoyl-GPC (18:0/18:2) measurement | 5.40e-04 | 6 | 179 | 2 | EFO_0800404 | |
| Disease | triglycerides to total lipids in very large HDL percentage | 5.55e-04 | 62 | 179 | 4 | EFO_0022339 | |
| Disease | total lipids in very large VLDL measurement | 5.55e-04 | 62 | 179 | 4 | EFO_0022313 | |
| Disease | phospholipids in very large VLDL measurement | 5.55e-04 | 62 | 179 | 4 | EFO_0022299 | |
| Disease | triglycerides in small LDL measurement | 6.64e-04 | 65 | 179 | 4 | EFO_0022323 | |
| Disease | Developmental Psychomotor Disorders | 7.53e-04 | 7 | 179 | 2 | C0751456 | |
| Disease | Psychomotor Disorders | 7.53e-04 | 7 | 179 | 2 | C0033922 | |
| Disease | Abnormality of the eye | 7.53e-04 | 7 | 179 | 2 | C4316870 | |
| Disease | MASA syndrome (implicated_via_orthology) | 7.53e-04 | 7 | 179 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | triglycerides in very small VLDL measurement | 7.88e-04 | 68 | 179 | 4 | EFO_0022144 | |
| Disease | triglycerides to phosphoglycerides ratio | 7.88e-04 | 68 | 179 | 4 | EFO_0022327 | |
| Disease | Parkinsonian Disorders | 7.90e-04 | 30 | 179 | 3 | C0242422 | |
| Disease | Severe Congenital Microcephaly | 8.71e-04 | 31 | 179 | 3 | C3853041 | |
| Disease | obsessive-compulsive symptom measurement | 8.71e-04 | 31 | 179 | 3 | EFO_0007802 | |
| Disease | cholesterol to total lipids in very large HDL percentage | 8.71e-04 | 31 | 179 | 3 | EFO_0022243 | |
| Disease | Early Childhood Epilepsy, Myoclonic | 1.00e-03 | 8 | 179 | 2 | C0393695 | |
| Disease | Idiopathic Myoclonic Epilepsy | 1.00e-03 | 8 | 179 | 2 | C0338478 | |
| Disease | Symptomatic Myoclonic Epilepsy | 1.00e-03 | 8 | 179 | 2 | C0338479 | |
| Disease | 1-palmitoyl-2-linoleoyl-GPC (16:0/18:2) measurement | 1.00e-03 | 8 | 179 | 2 | EFO_0800610 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 1.00e-03 | 8 | 179 | 2 | EFO_0008317, EFO_0008589, EFO_0008596 | |
| Disease | Benign Infantile Myoclonic Epilepsy | 1.00e-03 | 8 | 179 | 2 | C0751120 | |
| Disease | 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) measurement | 1.00e-03 | 8 | 179 | 2 | EFO_0800396 | |
| Disease | Myoclonic Encephalopathy | 1.00e-03 | 8 | 179 | 2 | C0438414 | |
| Disease | Uveal melanoma | 1.00e-03 | 8 | 179 | 2 | C0220633 | |
| Disease | Myoclonic Absence Epilepsy | 1.00e-03 | 8 | 179 | 2 | C0393703 | |
| Disease | Microlissencephaly | 1.05e-03 | 33 | 179 | 3 | C1956147 | |
| Disease | free cholesterol to total lipids in large LDL percentage | 1.08e-03 | 74 | 179 | 4 | EFO_0022280 | |
| Disease | Liver Diseases, Parasitic | 1.28e-03 | 9 | 179 | 2 | C0023897 | |
| Disease | protein CREG1 measurement | 1.28e-03 | 9 | 179 | 2 | EFO_0801937 | |
| Disease | uveal melanoma (is_marker_for) | 1.28e-03 | 9 | 179 | 2 | DOID:6039 (is_marker_for) | |
| Disease | Motor retardation | 1.28e-03 | 9 | 179 | 2 | C0424230 | |
| Disease | Myoclonic Epilepsy | 1.28e-03 | 9 | 179 | 2 | C0014550 | |
| Disease | monounsaturated fatty acids; 16:1, 18:1 measurement | 1.32e-03 | 78 | 179 | 4 | EFO_0022187 | |
| Disease | waist-hip ratio | DMXL2 ANK3 TMEM63C EZH1 TAOK2 P4HTM PTPRD SCUBE2 SCN4A TNRC6A COL14A1 TAOK1 TTC39A DOT1L RAB26 PHIP ZMYM4 | 1.34e-03 | 1226 | 179 | 17 | EFO_0004343 |
| Disease | cholesteryl esters to total lipids in very large HDL percentage | 1.35e-03 | 36 | 179 | 3 | EFO_0022257 | |
| Disease | complex trait | 1.39e-03 | 271 | 179 | 7 | EFO_0010578 | |
| Disease | fatty acid measurement | 1.44e-03 | 436 | 179 | 9 | EFO_0005110 | |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 1.47e-03 | 37 | 179 | 3 | EFO_0022252 | |
| Disease | triglyceride measurement, high density lipoprotein cholesterol measurement | 1.48e-03 | 274 | 179 | 7 | EFO_0004530, EFO_0004612 | |
| Disease | Colorectal Neoplasms | 1.57e-03 | 277 | 179 | 7 | C0009404 | |
| Disease | Uterine Cancer | 1.59e-03 | 10 | 179 | 2 | C0153567 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | Asthma, Occupational | 1.59e-03 | 10 | 179 | 2 | C0264423 | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | alopecia areata (is_marker_for) | 1.59e-03 | 10 | 179 | 2 | DOID:986 (is_marker_for) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | Epilepsy, Myoclonic, Infantile | 1.59e-03 | 10 | 179 | 2 | C0917800 | |
| Disease | 1-stearoyl-2-oleoyl-GPI (18:0/18:1) measurement | 1.59e-03 | 10 | 179 | 2 | EFO_0800469 | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | oleoyl-linoleoyl-glycerol (18:1/18:2) [2] measurement | 1.59e-03 | 10 | 179 | 2 | EFO_0800333 | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.59e-03 | 10 | 179 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Breast Carcinoma | 1.73e-03 | 538 | 179 | 10 | C0678222 | |
| Disease | Malignant neoplasm of liver | 1.78e-03 | 142 | 179 | 5 | C0345904 | |
| Disease | Liver neoplasms | 1.78e-03 | 142 | 179 | 5 | C0023903 | |
| Disease | cholesterol in very small VLDL measurement | 1.84e-03 | 40 | 179 | 3 | EFO_0022231 | |
| Disease | liver fibrosis measurement | 1.89e-03 | 86 | 179 | 4 | EFO_0010576 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PMGKAQEVSIDEEAY | 771 | Q14146 | |
| QVLSFDYDMGLDAPK | 96 | A6NC05 | |
| NEEEEFECYPPGMKV | 561 | Q4LE39 | |
| KGEENTVMIDYVLPD | 226 | Q9GZN1 | |
| EDIKRVEEMSGLYSP | 291 | Q8NHY2 | |
| EEEGLPMSYDEKRQL | 566 | Q15059 | |
| DKLNINPEDGMADYS | 446 | Q99459 | |
| FGLRPVDYTDDESMK | 526 | Q99728 | |
| EKDIMAEIYKNGPVE | 236 | P07858 | |
| AMQEGEYDAERPPSK | 906 | Q14203 | |
| LEMENTYPKDTERDG | 1736 | Q68DQ2 | |
| DKREDKLYDILPGME | 416 | Q9NQ94 | |
| GDMVLEKPYSEATAR | 681 | Q9Y4W6 | |
| YGDAAKMALVLEALP | 351 | Q14254 | |
| KSPYVDDMGAIGDEV | 1071 | Q5VU97 | |
| PIIDCMSEDGYKLDR | 401 | O95342 | |
| LERFYDPDQGKVMID | 1126 | O95342 | |
| YAKSPMQEEEDLAAG | 366 | Q92560 | |
| MKPEELVGVSEAYED | 491 | Q9P2G1 | |
| KVDDLLESYMGIRDP | 246 | Q8TF64 | |
| DQEEMVDKPDIGSYE | 2111 | Q8TDJ6 | |
| YGDKVMLVNPDDPDT | 66 | Q6P656 | |
| EKADIPAKYAETMDR | 186 | Q8TEK3 | |
| PKGRSEDDSYDDEML | 536 | P51828 | |
| KMEPQEVESLGETYD | 251 | P13497 | |
| LQKDFSVYRPADGDM | 241 | Q8TAM1 | |
| MAGELTPEEEAQYKK | 1 | Q9NZT1 | |
| IMDGASPDYVLVEAE | 1271 | Q03468 | |
| MRAIGFYPSEEKIDD | 991 | Q8TBY9 | |
| SIQEMYAAIKADPDG | 226 | Q9NXG6 | |
| DGEKLAKEYGLPFME | 191 | Q9ULW5 | |
| CEVFVGKIPRDMYED | 61 | Q8TBY0 | |
| DFSKMIDEAEPLGYP | 136 | Q8IXN7 | |
| AKYIMDLERLDPAGA | 236 | P52333 | |
| DYISPEILQAMEEGK | 236 | Q6DT37 | |
| DEDSPLYGMGKEELE | 266 | P48050 | |
| EGESYSKEVPEMEKR | 246 | P01210 | |
| LLPLDEEAVDMDYGD | 206 | Q9Y4B6 | |
| IIAYTDPELDMGDKK | 2756 | Q8NEZ4 | |
| EMKDEGEETLNYPDT | 766 | O60524 | |
| EIQPMKEDDGTFGEY | 1211 | Q92823 | |
| GIDDESYEAIFKPVM | 231 | Q13547 | |
| KKQEDGEEYVCPMEL | 916 | Q86W92 | |
| GFKPGLDMRLYEEDD | 941 | Q86W92 | |
| DLSEVDKDFIPGLMY | 4571 | O95714 | |
| DKDFIPGLMYIRDNE | 4576 | O95714 | |
| VGNYASDLELDPMKD | 401 | Q53G44 | |
| DEGAEKVMAYVPDAV | 771 | O43451 | |
| DVEFDYDGPLMKTEV | 36 | P80404 | |
| LGKLRMVADYEPEEE | 706 | Q9P1W3 | |
| SNGEPDEDAYDMRKA | 141 | P61599 | |
| ERDEVFEKEPLYGGM | 1936 | Q9Y6V0 | |
| ELVGIDYSLMKDPVA | 211 | P55058 | |
| METGTLYLAEEDPKE | 156 | P01213 | |
| KIVGYVLAKMEEDPD | 51 | P41227 | |
| YLEVFSMLRDEDGKP | 561 | Q16236 | |
| KFDGDIKQEPGMYRE | 311 | P50549 | |
| PKQLDMGDEVYDDVD | 641 | O15117 | |
| DMEPNVSVYSGLKEE | 366 | Q9H0H0 | |
| DEVMKSPGLYAIEEG | 336 | Q9H7Z3 | |
| VAAEKKDEGPYRMEH | 211 | P01189 | |
| DPDEKIAYGDVMLEN | 26 | Q13401 | |
| GVYLDDLTDMDPEVA | 396 | Q14693 | |
| KKQDESPMIGDGEDY | 91 | Q8N9Z9 | |
| LYQGLPAEVRDKMEE | 781 | Q6NSJ5 | |
| KEAEAEMQERYFEPL | 746 | Q7L590 | |
| MYARPGAVNEGDKDI | 256 | A6NET4 | |
| DEGMIYPELVLDKAL | 186 | Q9UN67 | |
| VGEKEMAAELEELYG | 481 | P23219 | |
| RAYLMAFQPGKLDED | 386 | Q6ZWE6 | |
| EAEAMKATEDGTPYD | 751 | P22059 | |
| MLEDAEDRKYPENDL | 766 | P29375 | |
| IEPAKPAMVDDESDY | 1246 | Q6ZV29 | |
| ELMDITKLYGEFADP | 1181 | O75694 | |
| PNVYIKNFGEDMDDE | 191 | Q9H361 | |
| DAMFYEIKIEAQDGP | 311 | Q9Y5H0 | |
| EELYRGMEADMPDEI | 61 | Q96A00 | |
| DEPLYIGNRMKKEDD | 561 | O94856 | |
| DEDIRDSGAKPVMVY | 191 | Q9NZ94 | |
| KMEAYVPSEEEKNGE | 2671 | Q8NFC6 | |
| EDALKAADTIGYPVM | 571 | P31327 | |
| IDDLTMVVYDPDKGS | 386 | Q9BYE9 | |
| GADKADRIYDDMPDI | 2381 | Q9C0G6 | |
| EDDPEEIRMEFIKYL | 151 | Q9H7X7 | |
| PSGYILEMRAEDTKE | 831 | Q8N9C0 | |
| GECAEPYMIFKEADA | 356 | Q96N67 | |
| KDPDILNGVYMSEAL | 216 | Q7Z3S7 | |
| YAPLTEGLAGDEKEM | 476 | Q05707 | |
| YETLLDEGPEMLEKQ | 671 | Q14CM0 | |
| EEMIEKAKGETAYLP | 26 | P78310 | |
| YKDGRPLTDDEVAGM | 296 | Q16850 | |
| VRKANAPEMLSDGEY | 851 | Q12955 | |
| GEQDHRVDMKAIEPY | 136 | Q12982 | |
| LEEEYRKGAREDDPM | 3211 | Q99698 | |
| LVLDGTIEYMRDPDD | 46 | Q9UK45 | |
| IELEEDMYKGGKADQ | 761 | Q9GZR7 | |
| MEYVFELDVPGKVED | 131 | Q92636 | |
| DDLEAGPMDLYLSAA | 381 | Q9H9L4 | |
| KVLADMFGEEESYNP | 776 | P55289 | |
| DPLDAYMEEVKEEVK | 226 | Q7L014 | |
| EDADFDNKPMVLLVG | 51 | Q9H4M9 | |
| KPAEMIEVDGDANSY | 541 | Q7Z3Z3 | |
| LPIEDDCGDYLVMRK | 856 | Q9NQ36 | |
| VEVLLPDEGMQKYDK | 381 | Q9UDX4 | |
| ASYIPEDEALMLRDG | 26 | Q9BWG6 | |
| EDMKEKPDAESVVYL | 141 | Q9UJQ4 | |
| KANDPDVGENAEMEY | 291 | Q9ULB4 | |
| PYVLEDSLEMNAKGV | 76 | Q16820 | |
| PADFKVDEDGMVYAV | 76 | P19022 | |
| LRSDGVMGEYEPKIE | 216 | Q9P232 | |
| ADAIMSPEEELDGYE | 116 | Q07820 | |
| MGEPSREEYKIQSFD | 1 | A9UHW6 | |
| PIYIAEMEKEEKQGD | 201 | Q5VU65 | |
| KILYDDGKMVEEVDG | 1051 | P23468 | |
| GAEMLEEEPLYVNAK | 256 | P23511 | |
| DEGMIYPELVLDKAL | 186 | Q9Y5E1 | |
| ERESVEKPDSYMEGA | 706 | Q92834 | |
| RDGKDQDEDLMPEYK | 81 | Q96PL5 | |
| EERELQMDPADYGKQ | 416 | Q6P4E1 | |
| MPDYLGADQRKTKED | 1 | P35998 | |
| LEDEYPDMPTEGIKN | 141 | Q9H9J2 | |
| GIAMIADKYPEEPER | 196 | Q16572 | |
| LSMKEGDPAIYAERA | 241 | Q9UGI8 | |
| KPLDIDYMGEEQLRA | 191 | P13805 | |
| SDLEAGKNLPMIYGD | 56 | P35499 | |
| MDRYEAEALLEGKPE | 386 | O75159 | |
| LEYPGQAPEAEKDKM | 371 | Q24JP5 | |
| CEDMGLKDPEELRNY | 1001 | Q24JP5 | |
| MATLIYVDKENEEPG | 1 | Q9NZH4 | |
| MGDEDKRITYEDSEP | 1 | Q86UD5 | |
| MDKYAAEALLEGKPE | 291 | Q8WXH5 | |
| ETYPKERATEGIAME | 531 | Q96ST3 | |
| PEVILAMDEGQYDGK | 191 | Q7L7X3 | |
| PEVILAMDEGQYDGK | 191 | Q9UL54 | |
| DVYAMNPPKFDRIED | 76 | P11055 | |
| QEKPREIMDAAEDYA | 11 | P14868 | |
| VIYDSDMDDVPERGL | 416 | Q6UXD5 | |
| DYAEPMDAVVKPRNE | 1086 | Q9NRY4 | |
| EDADFDNKPMVLLVG | 51 | Q9NZN3 | |
| LYPAEPVMVGAEAED | 281 | Q92502 | |
| NPEDMGDLYLDVAEA | 416 | Q9Y5Q9 | |
| ENLGKKMSEDLPYEV | 76 | P45381 | |
| KEPYSDMTDEKGRED | 641 | Q0P6D6 | |
| DDDSYDGKMNLPVVL | 56 | Q8NEL0 | |
| KAADGPVDEYMLPFE | 401 | Q13705 | |
| TEADPEMIKRAEDYG | 216 | O96005 | |
| YVPAQRKADLDEEMI | 201 | Q8NHS4 | |
| EDEKNKEVYMTPLRG | 921 | Q9BPX3 | |
| EKMVDILAGPDAYRD | 196 | Q96SZ6 | |
| EGGPELEKVAMEDYK | 201 | Q8IWZ8 | |
| RLSEMLEEEDYPGAI | 186 | Q96JG6 | |
| NVYAPEDDPEMKVER | 416 | O75312 | |
| MEYCLEVIKENDPSG | 441 | Q6ZTA4 | |
| DGSDMSAIIYEIPKE | 431 | Q96CK0 | |
| EAGNYESPMELCKDV | 1371 | Q8WWQ0 | |
| SYDEAVKMAKPREEG | 156 | Q8NDY8 | |
| DEELDAMFPEGYKVL | 401 | O75533 | |
| LLDDYKEGDLRIMPD | 181 | Q9Y657 | |
| EQEYGEPFLAAMEKL | 136 | Q9BSI4 | |
| DPIIYQGIMDKDEEK | 1041 | P22105 | |
| NIPYMGDEVKEEDET | 131 | Q92800 | |
| FYAAVEMRDNPELKD | 111 | Q9UBT6 | |
| QGPDEKMVKYIDSED | 1641 | Q9HCK1 | |
| EPDGTEVADKAGYLM | 376 | Q9UKX3 | |
| DPMGKEGDFVYKEVI | 426 | O94885 | |
| EPEPVYIDEDKMDRA | 286 | O75886 | |
| REGMTDEEALVPYSK | 1306 | Q9HCK4 | |
| GGDKLETMPLYLEDD | 31 | O00767 | |
| EYMEKIGSSLPQDDD | 2526 | O95359 | |
| GYEMSKPDLRAELEA | 576 | Q13472 | |
| GLLESVYEMFRKDDP | 1796 | P78527 | |
| AGEMELKPFNGEDYT | 201 | P11388 | |
| DMNVDFDAPLGYKEP | 186 | Q92890 | |
| EYIPTDPLDDNRMGK | 216 | P86452 | |
| ETETIAKYEIMDGAP | 226 | O75436 | |
| KFVGSYMIPDNEDRD | 226 | O15041 | |
| YMKEPGEADPAIQEE | 741 | Q9BTW9 | |
| ELKTGYLSIVMDPDE | 796 | P35968 | |
| PEVMEQVRGYDFKAD | 241 | Q9UEW8 | |
| LLKADEPIADYAAMD | 1001 | Q86UV5 | |
| EAMAEKFLEGEVPLE | 116 | A5D8V6 | |
| KAEEMLEKGPENEYS | 486 | Q5SRH9 | |
| PLGMKGEIAEAYADL | 351 | P51784 | |
| KEYLSLMAELGEAPV | 311 | Q15637 | |
| MERNPYFDKDGIVAD | 1271 | Q8NDV7 | |
| EEPLDDEYDKAMAPQ | 251 | Q5VZL5 | |
| DEYDKAMAPQQGLLD | 256 | Q5VZL5 | |
| LDHYEMKEEEPAEGK | 201 | Q7Z7E8 | |
| PMAASAEYELEKRVE | 476 | Q96SB3 |